Samuel N. Hazen - Feb 3, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
CEO, Director
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Feb 3, 2023
Transactions value $
-$4,243,601
Form type
4
Date filed
2/7/2023, 05:40 PM
Previous filing
Feb 1, 2023
Next filing
Feb 22, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $4.07M +59K +74.79% $68.96 138K Feb 3, 2023 Direct
transaction HCA Common Stock Tax liability -$8.31M -32.2K -23.36% $258.08 106K Feb 3, 2023 Direct
holding HCA Common Stock 813K Feb 3, 2023 By LP
holding HCA Common Stock 300K Feb 3, 2023 By 2022 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -59K -100% $0.00* 0 Feb 3, 2023 Common Stock 59K $68.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.